WWOX in biological control and tumorigenesis

Journal of Cellular Physiology

Volumn 212, Issue 2, 2007, Pages 307-310

  Aqeilan, Rami I ^a,b   Croce, Carlo M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL SEQUENCE; BIOCHEMISTRY; BIOLOGICAL PEST CONTROL; CARCINOGENESIS; CHROMOSOME 16Q; CHROMOSOME FRAGILE SITE; GENE; GENE DELETION; GENE LOCATION; HUMAN; INCIDENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SHORT SURVEY; TUMOR SUPPRESSOR GENE; WWOX GENE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; ENZYME REPRESSION; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, TRANSGENIC; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; OXIDOREDUCTASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 34347371806     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21099     Document Type: Short Survey

References (45)

1. Aqeilan RI, Kuroki T, Pekarsky Y, Albagha O, Trapasso F, Baffa R, Huebner K, Edmonds P, Croce CM. 2004a. Loss of WWOX expression in gastric carcinoma. Clin Cancer Res 10:3053-3058.
2. Aqeilan RI, Palamarchuk A, Weigel RJ, Herrero JJ, Pekarsky Y, Croce CM. 2004b. Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor. Cancer Res 64:8256-8261.
3. Aqeilan RI, Pekarsky Y, Herrero JJ, Palamarchuk A, Letofsky J, Druck T, Trapasso F, Han SY, Melino G, Huebner K, Croce CM. 2004c. Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci USA 101:4401-4406.
4. Aqeilan RI, Donati V, Palamarchuk A, Trapasso F, Kaou M, Pekarsky Y, Sudol M, Croce CM. 2005. WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res 65:6764-6772.
5. Aqeilan RI, Trapasso F, Hussain S, Costinean S, Marshall D, Pekarsky Y, Hagan JP, Zanesi N, Kaou M, Stein GS, ban JB, Croce CM. 2007. Targeted deletion of Wwox reveals a tumor suppressor function. PNAS 104:3949-3954.
6. Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM. 2000. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23 3-24.1, a region frequently affected in breast cancer. Cancer Res 60:2140-2145.
7. Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ, Aldaz CM. 2001. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res 61:8068-8073.
8. Chang NS, Schultz L, Hsu LJ, Lewis J, Su M, Sze CI. 2005. 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: Potential role in cancerous progression of breast and prostate to a premetastatic state in vivo. Oncogene 24:714-723.
9. Chang NS, Hsu LJ, Lin YS, Lai FJ, Sheu HM. 2007. WW domain-containing oxidoreductase: A candidate tumor suppressor. Trends Mol Med 13:12-22.
10. Chen T, Sahin A, Aldaz CM. 1996. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: Refining a putative tumor suppressor gene region. Cancer Res 56:5605-5609.
11. Donati V, Fontanini G, Dell'Omodarme M, Prati MC, Nuti S, Lucchi M, Mussi A, Fabbri M, Basolo F, Croce CM, Aqeilan RI. 2007. WWOX expression in different histological types and subtypes of non-small cell lung cancer. Clin Cancer Res 13:884-891.
12. Fabbri M, Iliopoulos D, Trapasso F, Aqeilan RI, Cimmino A, Zanesi N, Yendamuri S, Han SY, Amadon D, Huebner K, Croce CM. 2005. WWOX gene restoration prevents lung cancer growth in vitro and in vivo. Proc Natl Acad Sci USA 102:15611-15616.
13. Finnis M, Dayan S, Hobson L, Chenevix-Trench G, Friend K, Ried K, Venter D, Woollatt E, Baker E, Richards RI. 2005. Common chromosomal fragile site FRA16D mutation in cancer cells. Hum Mol Genet 14:1341-1349.
14. Gaudio E, Palamarchuk A, Palumbo T, Trapasso F, Pekarsky Y, Croce CM, Aqeilan RI. 2006. Physical association with WWOX suppresses c-Jun transcriptional activity. Cancer Res 66:11585-11589.
15. Guler G, Uner A, Guler N, Han SY, Iliopoulos D, Hauck WW, McCue P, Huebner K. 2004. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Cancer 100:1605-1614.
16. Hahn WC, Weinberg RA. 2002. Rules for making human tumor cells. N Engl J Med 347:1593-1603.
17. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
18. Hu H, Columbus J, Zhang Y, Wu D, Lian L, Yang S, Goodwin J, Luczak C, Carter M, Chen L, James M, Davis R, Sudol M, Rodwell J, Herrero JJ. 2004. A map of WW domain family interactions. Proteomics 4:643-655.
19. Huebner K, Croce CM. 2001. FRA3B and other common fragile sites: The weakest links. Nat Rev Cancer 1:214-221.
20. Iliopoulos D, Guler G, Han SY, Johnston D, Druck T, McCorkell KA, Palazzo J, McCue PA, Baffa R, Huebner K. 2005. Fragile genes as biomarkers: Epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene 24:1625-1633.
21. Iliopoulos D, Fabbri M, Druck T, Qin HR, Han SY, Huebner K. 2007. Inhibition of breast cancer cell growth in vitro and in vivo: Effect of restoration of wwox expression. Clin Cancer Res 13:268-274.
22. Jin C, Ge L, Ding X, Chen Y, Zhu H, Ward T, Wu F, Cao X, Wang Q, Yao X. 2006. PKA-mediated protein phosphorylation regulates ezrin-WWOX interaction. Biochem Biophys Res Commun 341:784-791.
23. Junttila TT, Sundvall M, Lundin M, Lundin J, Tanner M, Harkonen P, Joensuu H, Isola J, Elenius K. 2005. Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells. Cancer Res 65:1384-1393.
24. Komuro A, Nagai M, Navin NE, Sudol M. 2003. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem 278:33334-33341.
25. Krummel KA, Denison SR, Calhoun E, Phillips LA, Smith DI. 2002. The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8 E1. Genes Chromosomes Cancer 34:154-167.
26. Kuroki T, Trapasso F, Shiraishi T, Alder H, Mimori K, Mori M, Croce CM. 2002. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res 62:2258-2260.
27. Kuroki T, Yendamuri S, Trapasso F, Matsuyama A, Aqeilan RI, Alder H, Rattan S, Cesari R, Nolli ML, Williams NN, Mori M, Kanematsu T, Croce CM. 2004. The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res 10:2459-2465.
28. Latil A, Cussenot O, Fournier G, Driouch K, Lidereau R. 1997. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: Identification of three independent regions. Cancer Res 57:1058-1062.
29. Ludes-Meyers JH, Bednarek AK, Popescu NC, Bedford M, Aldaz CM. 2003. WWOX, the common chromosomal fragile site, FRA16D, cancer gene. Cytogenet Genome Res 100:101-110.
30. Ludes-Meyers JH, Kil H, Bednarek AK, Drake J, Bedford MT, Aldaz CM. 2004. WWOX binds the specific proline-rich ligand PPXY: Identification of candidate interacting proteins. Oncogene 23:5049-5055.
31. Maatta JA, Sundvall M, Junttila TT, Peri L, Laine VJ, Isola J, Egeblad M, Elenius K. 2006. Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth. Mol Biol Cell 17:67-79.
32. Mangelsdorf M, Ried K, Woollatt E, Dayan S, Eyre H, Finnis M, Hobson L, Nancarrow J, Venter D, Baker E, Richards RI. 2000. Chromosomal fragile site FRA16D and DNA instability in cancer. Cancer Res 60:1683-1689.
33. Nunez MI, Ludes-Meyers J, Abba MC, Kil H, Abbey NW, Page RE, Sahin A, Klein-Szanto AJ, Aldaz CM. 2005a. Frequent loss of WWOX expression in breast cancer: Correlation with estrogen receptor status. Breast Cancer Res Treat 89:99-105.
34. Nunez MI, Rosen DG, Ludes-Meyers JH, Abba MC, Kil H, Page R, Klein-Szanto AJ, Godwin AK, Liu J, Mills GB, Aldaz CM. 2005b. WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. BMC Cancer 5:64.
35. Nunez MI, Ludes-Meyers J, Aldaz CM. 2006. WWOX protein expression in normal human tissues. J Mol Histol 37:115-125.
36. O'Keefe LV, Richards RI. 2006. Common chromosomal fragile sites and cancer: Focus on FRA16D. Cancer Lett 232:37-47.
37. Paige AJ, Taylor KJ, Stewart A, Sgouros JG, Gabra H, Sellar GC, Smyth JF, Porteous DJ, Watson JE. 2000. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res 60:1690-1697.
38. Paige AJ, Taylor KJ, Taylor C, Hillier SG, Farrington S, Scott D, Porteous DJ, Smyth JF, Gabra H, Watson JE. 2001. WWOX: A candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci USA 98:11417-11422.
39. Park SW, Ludes-Meyers J, Zimonjic DB, Durkin ME, Popescu NC, Aldaz CM. 2004. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. Br J Cancer 91:753-759.
40. Pimenta FJ, Gomes DA, Perdigao PF, Barbosa AA, Romano-Silva MA, Gomez MV, Aldaz CM, De Marco L, Gomez RS. 2006. Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas. Int J Cancer 118:1154-1158.
41. Qin HR, Iliopoulos D, Semba S, Fabbri M, Druck T, Volinia S, Croce CM, Morrison CD, Klein RD, Huebner K. 2006. A role for the WWOX gene in prostate cancer. Cancer Res 66:6477-6481.
42. Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow JK, Woollatt E, Kremmidiotis G, Gardner A, Venter D, Baker E, Richards RI. 2000. Common chromosomal fragile site FRA16D sequence: Identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet 9:1651-1663.
43. Sudol M, Recinos CC, Abraczinskas J, Humbert J, Farooq A. 2005. WW or WoW: The WW domains in a union of bliss. IUBMB Life 57:773-778.
44. Yendamuri S, Kuroki T, Trapasso F, Henry AC, Dumon KR, Huebner K, Williams NN, Kaiser LR, Croce CM. 2003. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Res 63:878-881.
45. Yu S, Mangelsdorf M, Hewett D, Hobson L, Baker E, Eyre HJ, Lapsys N, Le Paslier D, Doggett NA, Sutherland GR, Richards RI. 1997. Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell 88:367-374.